Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.

Saved in:
Bibliographic Details
Title: Higher mortality associated with the SARS-CoV-2 Delta variant in the Western Cape, South Africa, using RdRp target delay as a proxy: a cross-sectional study.
Authors: Hussey H; Health Intelligence, Western Cape Government: Health, Cape Town, South Africa.; Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Davies MA; Health Intelligence, Western Cape Government: Health, Cape Town, South Africa.; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Heekes A; Health Intelligence, Western Cape Government: Health, Cape Town, South Africa.; Division of Public Health Medicine, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Williamson C; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Valley-Omar Z; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Hardie D; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Korsman S; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Doolabh D; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Preiser W; National Health Laboratory Service, Cape Town, South Africa.; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Maponga T; National Health Laboratory Service, Cape Town, South Africa.; Division of Medical Virology, Stellenbosch University, Cape Town, South Africa., Iranzadeh A; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa., Engelbrecht S; National Health Laboratory Service, Cape Town, South Africa., Wasserman S; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa., Schrueder N; Department of Medicine, Tygerberg Hospital,, Stellenbosch University, Cape Town, South Africa., Boloko L; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Symons G; Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Raubenheimer P; Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa., Viljoen A; Department of Medicine, Tygerberg Hospital,, Stellenbosch University, Cape Town, South Africa., Parker A; Department of Medicine, Tygerberg Hospital,, Stellenbosch University, Cape Town, South Africa., Cohen C; National Institute for Communicable Diseases, Johannesburg, South Africa.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Jasat W; National Institute for Communicable Diseases, Johannesburg, South Africa., Lessells R; KwaZulu-Natal Research, Innovation & Sequencing Platform, University of KwaZulu Natal, Durban, South Africa., Wilkinson RJ; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; The Francis Crick Institute, London, UK.; Department of Infectious Diseases, Imperial College London, London, UK., Boulle A; Health Intelligence, Western Cape Government: Health, Cape Town, South Africa.; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa., Hsiao M; Division of Medical Virology, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.; National Health Laboratory Service, Cape Town, South Africa.
Source: Gates open research [Gates Open Res] 2022 Aug 31; Vol. 6, pp. 117. Date of Electronic Publication: 2022 Aug 31 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Bill and Melinda Gates Foundation Country of Publication: United States NLM ID: 101717821 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-4754 (Electronic) Linking ISSN: 25724754 NLM ISO Abbreviation: Gates Open Res Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2572-4754
DOI:10.12688/gatesopenres.13654.1